References.
American Psychiatric Association. (2022). Substance-Related and Addictive Disorders. In Diagnostic and Statistical Manual of Mental
Disorders (5th ed., text rev.). https://doi/book/10.1176/appi.books.9780890425787
Australian Department of Health (2017). National Drug Strategy 2017-2026. https://www.health.gov.au/sites/default/files/national-
drug-strategy-2017-2026.pdf
Australian Institute of Health and Welfare. (2025a, June 27). Alcohol, tobacco & other drugs in Australia.
Australian Institute of Health and Welfare. (2025b, June 27). Illicit drug use. https://www.aihw.gov.au/reports/illicit-use-of-drugs/illicit-
drug-use
Australian Institute of Health and Welfare. (2025c, August 19). Mental health and Substance Use. https://www.aihw.gov.au/mental-
health/topic-areas/health-wellbeing/mental-illness-and-substance-use
Bryant, J., Horwitz, R., Gray, R. M., Lafferty, L., Jops, P., Blunden, H., Hudson, S., & Brener, L. (2022). Improving access to drug and
alcohol treatment in NSW Australia: The role of self-determination and peer support. Health & Social Care in the Community, 30(5), e2050–e2057. https://doi.org/10.1111/hsc.13639
Corace, K., Thavorn, K., Suschinsky, K., Willows, M., Leece, P., Kahan, M., Nijmeh, L., Aubin, N., Roach, M., Garner, G., Saskin, R., Kim, E.,
Rice, D., Taha, S., Garber, G., & Hutton, B. (2023). Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use. JAMA Network Open, 6(11), e2344528. https://doi.org/10.1001/jamanetworkopen.2023.44528
Corredor-Waldron, A., & Currie, J. (2022). "Tackling the Substance Use Disorder Crisis: The Role of Access to Treatment Facilities".
Journal of Health Economics, 81, 102579. https://doi.org/10.1016/j.jhealeco.2021.102579
Farhoudian, A., Razaghi, E., Hooshyari, Z., Noroozi, A., Pilevari, A., Mokri, A., Mohammadi, M. R., & Malekinejad, M. (2022). Barriers and
Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews. Substance Abuse: Research and Treatment, 16, 11782218221118462. https://doi.org/10.1177/11782218221118462
Fisher, A., Rochesson, S.E.D., Mills, K., & Marel, C. (2024). Guiding Principles for Managing Co-occurring Alcohol/Other Drug and Mental
Health Conditions: a Scoping Review. International Journal of Mental Health Addiction, 22, 1251–1298
https://doi.org/10.1007/s11469-022-00926-7
Francia, L., Lam, T., Berg, A., Morgan, K., Savic, M., Lubman, D. I., & Nielsen, S. (2023). Putting out the welcome mat-A qualitative
exploration of service delivery processes and procedures as barriers to treatment-seeking for people who use alcohol and other
drugs. Drug and Alcohol Review, 42(1),193–202. https://doi.org/10.1111/dar.13551
Global Burden of Disease Collaborative Network. Findings from the Global Burden of Disease Study 2021 (GBD 2021).
https://www.healthdata.org/research-analysis/library/global-burden-disease-2021-findings-gbd-2021-
study#:~:text=Citation,%2C%20WA:%20IHME%2C%202024.
Health Stats NSW. (2025, May). Alcohol and other drugs. https://www.healthstats.nsw.gov.au/topic-
overview/Alcohol%20and%20other%20drugs/Western%20Sydney%20PHN/westernsydneyphn/PHN
McKenzie, D., & Mu, T. (2025, February 13-14). Nurse practitioner-led rapid OAT access within the MSIR. [Presentation]. The Victorian
Alcohol and Drug Association Inc. (VAADA), Melbourne, Vic., Australia. https://www.vaada.org.au/wp-
content/uploads/2025/02/Slides_D2_S4_Verandah_1.pdf
Neale, J., Cairns, B., Gardiner, K., Livingston, W., McCarthy, T., & Perkins, A. (2024). Waiting for inpatient detoxification: A qualitative
analysis of patient experiences. The International Journal on Drug Policy, 123, 104291. https://doi.org/10.1016/j.drugpo.2023.104291
O’Reilly, K., & Ritter, A. (2024). Estimates of unmet demand for alcohol and other drug treatment in NSW. Drug Policy Modelling Program:
Evidence hub for the NSW Drug Summit 2024. https://www.unsw.edu.au/content/dam/pdfs/ada/sprc/research-reports/dpmp-
drug-summit-2024-explainers/2024-10-how-many-people-miss-out-on-alcohol-and-other-drug-treatment-in-nsw-dpmp-2024-
v2.pdf
Penington Institute. (2024). Australia’s Annual Overdose Report. https://www.penington.org.au/wp-
content/uploads/2024/08/PEN_Annual-Overdose-Report-2024.pdf
Richardson, W. S., Wilson, M. C., Nishikawa, J., & Hayward, R. S. (1995). The well-built clinical question: a key to evidence-based
decisions. ACP Journal Club, 123(3), A12–A13.
Ritter, A., & O'Reilly, K. (2025). Unmet treatment need: The size of the gap for alcohol and other drugs in Australia. Drug and Alcohol
Review, 44(3), 772–782. https://doi.org/10.1111/dar.14008
Rubenis, A.J., Barnett, A.I., & Arunogiri. S. (2024). Keeping clients connected: exploring Australian alcohol and other drug clinicians’
perspectives on barriers and facilitators to treatment attendance, Addiction Research & Theory, 32(2), 120-128.
https://doi.org/10.1080/16066359.2023.2227092
Roy, P. J., Choi, S., Bernstein, E., & Walley, A. Y. (2020). Appointment wait-times and arrival for patients at a low-barrier access addiction
clinic. Journal of Substance Abuse Treatment, 114, 108011. https://doi.org/10.1016/j.jsat.2020.108011
Ryan, A., Holmes, J., Hunt, V., Dunlop, A., Mammen, K., Holland, R., Sutton, Y., Sindhusake, D., Rivas, G., & Lintzeris, N. (2014). Validation
and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings. Drug and Alcohol Review,
33(1), 33–42. https://doi.org/10.1111/dar.12083
Sander, K., Wilson, H., Kelly, J., & Bligh, A. (2020). Examination of a group entry model into alcohol and other drug (AOD) treatment:
Improvements in attendance, retention, and clinical capacity. Substance Abuse, 41(1), 19–23.
https://doi.org/10.1080/08897077.2019.1635064
Srivastava, A., Clarke, S., Hardy, K., & Kahan, M. (2021). Facilitating rapid access to addiction treatment: a randomized controlled trial.
Addiction Science & Clinical Practice, 16(1), 34. https://doi.org/10.1186/s13722-021-00240-y
Taylor, J. L., Johnson, S., Cruz, R., Gray, J. R., Schiff, D., & Bagley, S. M. (2021). Integrating Harm Reduction into Outpatient Opioid Use
Disorder Treatment Settings: Harm Reduction in Outpatient Addiction Treatment. Journal of General Internal Medicine, 36(12),
3810–3819. https://doi.org/10.1007/s11606-021-06904-4
Williams, J., & Bretteville-Jensen, A.L. (2022). What’s Another Day? The Effects of Wait Time for Substance Abuse Treatment on Health-
Care Utilization, Employment and Crime. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4114629
World Health Organization and United Nations Office on Drugs and Crime (2020). International standards for the treatment of drug use
disorders. https://iris.who.int/server/api/core/bitstreams/82b4508a-c1ad-4561-9a4c-de29e43a70f9/content